Which Hedge Funds Own TRAX — First Tracks Biotherapeutics I

9 of the hedge funds we track hold TRAX, worth $111.4M combined as of the Q2 2026 13F filings.

Versus the prior quarter: 9 opened a new position.

8 of those are hedged quant multi-strategy books, not directional conviction.

• EcoR1 Capital — $63.9M (NEW)
• Adage Capital Management — $14.7M (NEW)
• Balyasny Asset Management — $14.4M (NEW)

Insider buying at TRAX · All tracked funds